Tang Q - Search Results

1

The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.

Dong S, Hiam-Galvez KJ, Mowery CT, Herold KC, Gitelman SE, Esensten JH, Liu W, Lares AP, Leinbach AS, Lee M, Nguyen V, Tamaki SJ, Tamaki W, Tamaki CM, Mehdizadeh M, Putnam AL, Spitzer MH, Ye CJ, Tang Q, Bluestone JA. Dong S, et al. Among authors: tang q. JCI Insight. 2021 Sep 22;6(18):e147474. doi: 10.1172/jci.insight.147474. JCI Insight. 2021. PMID: 34324441 Free PMC article. Clinical Trial.

2

The Src family kinase Fyn mediates signals induced by TCR antagonists.

Tang Q, Subudhi SK, Henriksen KJ, Long CG, Vives F, Bluestone JA. Tang Q, et al. J Immunol. 2002 May 1;168(9):4480-7. doi: 10.4049/jimmunol.168.9.4480. J Immunol. 2002. PMID: 11970992

3

CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment.

Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. Bour-Jordan H, et al. Among authors: tang q. Nat Immunol. 2003 Feb;4(2):182-8. doi: 10.1038/ni884. Epub 2003 Jan 13. Nat Immunol. 2003. PMID: 12524538

4

CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.

Tang Q, Smith JA, Szot GL, Zhou P, Alegre ML, Henriksen KJ, Thompson CB, Bluestone JA. Tang Q, et al. J Immunol. 2003 Feb 1;170(3):1510-6. doi: 10.4049/jimmunol.170.3.1510. J Immunol. 2003. PMID: 12538715

5

Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, Subudhi SK, Zheng XX, Strom TB, Bluestone JA. Tang Q, et al. J Immunol. 2003 Oct 1;171(7):3348-52. doi: 10.4049/jimmunol.171.7.3348. J Immunol. 2003. PMID: 14500627

6

The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells.

Boden E, Tang Q, Bour-Jordan H, Bluestone JA. Boden E, et al. Among authors: tang q. Novartis Found Symp. 2003;252:55-63; discussion 63-6, 106-14. doi: 10.1002/0470871628.ch5. Novartis Found Symp. 2003. PMID: 14609212 Review.

7

Notch 1 signaling regulates peripheral T cell activation.

Eagar TN, Tang Q, Wolfe M, He Y, Pear WS, Bluestone JA. Eagar TN, et al. Among authors: tang q. Immunity. 2004 Apr;20(4):407-15. doi: 10.1016/s1074-7613(04)00081-0. Immunity. 2004. PMID: 15084270 Free article.

8

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA. Tang Q, et al. J Exp Med. 2004 Jun 7;199(11):1455-65. doi: 10.1084/jem.20040139. J Exp Med. 2004. PMID: 15184499 Free PMC article.

9

Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.

Bluestone JA, Tang Q. Bluestone JA, et al. Among authors: tang q. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14622-6. doi: 10.1073/pnas.0405234101. Epub 2004 Aug 20. Proc Natl Acad Sci U S A. 2004. PMID: 15322272 Free PMC article. Review.

10

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.

Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA. Tang Q, et al. Eur J Immunol. 2004 Nov;34(11):2996-3005. doi: 10.1002/eji.200425143. Eur J Immunol. 2004. PMID: 15468055 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,165 results

Search Page